CSURE.TA - Cannassure Therapeutics Ltd

Tel Aviv - Tel Aviv Delayed Price. Currency in USD
254.00
+1.80 (+0.71%)
As of 2:24PM IDT. Market open.
Stock chart is not supported by your current browser
Previous Close252.20
Open255.00
Bid254.10 x 0
Ask254.80 x 0
Day's Range250.20 - 260.00
52 Week Range219.30 - 260.00
Volume118,793
Avg. Volume0
Market Cap129.963M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.96
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire3 months ago

    Cannabis Pushes Advancement in Agritech

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the new agritech wave of innovation in the cannabis sector. Since the passage of the Farm Bill late last year, the development and distribution of CBD and hemp products nationwide has greatly expanded, creating a need for new agricultural technologies. EnviroTechnologies International, Inc. (ETII), a company that develops and markets green, natural and organic products, recently confirmed that it is preparing to introduce its patent pending water treatment technology to licensed cannabis growers in the northwest.

  • Cannassure Therapeutics Announces Strategic Partnership With Cannika Holdings
    PR Newswire3 months ago

    Cannassure Therapeutics Announces Strategic Partnership With Cannika Holdings

    ASHDOD, Israel, Jan. 30, 2019 /PRNewswire/ -- Cannassure Therapeutics (CSURE.TA) announces its collaboration with Cannika Holdings, an agritech incubator specializing in cannabis innovation.  Cannika will operate out of the Cannassure campus, utilizing their many facilities that are designed to meet the highest regulatory standards.

  • CNW Group3 months ago

    Cannassure Exits the Maintenance List and Starts Renewal of Trading on Tel Aviv Stock Exchange's (TASE) Main List

    ASHDOD, Israel , Jan. 15, 2019 /CNW/ - Cannassure Therapeutics Ltd. (CSURE.TA), designed to grow, extract and develop medical cannabis, announces its renewed trading on the TASE after completing its reverse merger and move from the TASE maintenance list. This was made possible by a private investment of 17.5 million NIS , in cash, from Solbar Food Technologies, the company's controlling shareholder. Cannassure's shareholder equity is estimated at 25 million NIS , mainly in cash, and is designated towards advancing infrastructure and new product development.